BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin D, Yu X, Chen B, Li Z, Ding J, Zhao X, Qi G. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model. Immunotherapy 2017;9:537-53. [PMID: 28509606 DOI: 10.2217/imt-2017-0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Zhou X, Sha H, Xie L, Liu B. Recent Progress on Therapeutic Vaccines for Breast Cancer. Front Oncol 2022;12:905832. [PMID: 35734599 DOI: 10.3389/fonc.2022.905832] [Reference Citation Analysis]
2 Lin S, Jiang X, Zhang G, Xiao X, Ma X, Wu J, Qiu D, Li X, Yan X, Ma M. The Chinese Herbal Formula Ruyan Neixiao Cream Inhibits Angiogenesis of Precancerous Breast Lesions via Regulation of Ras/Raf/MEK/ERK Signaling Pathway. Integr Cancer Ther 2022;21:153473542110693. [DOI: 10.1177/15347354211069397] [Reference Citation Analysis]
3 Wang Y, Dong L, Wan F, Chen F, Liu D, Chen D, Long J. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH. Cell Death Dis 2021;12:861. [PMID: 34552061 DOI: 10.1038/s41419-021-04145-1] [Reference Citation Analysis]
4 Gordon B, Gadi VK. The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines (Basel) 2020;8:E529. [PMID: 32937885 DOI: 10.3390/vaccines8030529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li Z, Ding J, Zhao X, Qi G. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin. Immunotherapy 2018;10:951-69. [PMID: 30114953 DOI: 10.2217/imt-2017-0194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]